NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 609 / 982

  1. Moving beyond the other2016 · OpenAlex
  2. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.2016 · PubMed
  3. Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain.2016 · PubMed
  4. Mujeres, consumo de drogas y encarcelamiento. Una aproximación interseccional2016 · Crossref
  5. Multi-morbidity: Psychosis early childhood adversity and substance use within homeless people2016 · Crossref
  6. Multianalytical Method Validation for Qualitative and Quantitative Analysis of Solvents of Abuse in Oral Fluid by HS-GC/MS2016 · OpenAlex
  7. Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia2016 · OpenAlex
  8. Multisystem toxicity after methamphetamine use2016 · OpenAlex
  9. Multi‐class analysis of new psychoactive substances and metabolites in hair by pressurized liquid extraction coupled to HPLC‐HRMS2016 · Crossref
  10. Mushroom Sacraments in the Cults of Early Europe2016 · OpenAlex
  11. Mutational signatures associated with tobacco smoking in human cancer2016 · OpenAlex
  12. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects2016 · OpenAlex
  13. Nabilone for the Management of Pain2016 · OpenAlex
  14. Nalmefene and alcohol use disorder. Evaluation of clinical cases at a treatment centre for drug addicts2016 · Crossref
  15. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans2016 · OpenAlex
  16. Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases2016 · OpenAlex
  17. Narcissistic Vulnerability and Addiction2016 · Crossref
  18. Narrative Criminology2016 · OpenAlex
  19. National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–20142016 · OpenAlex
  20. National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 20122016 · OpenAlex
  21. National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults.2016 · PubMed
  22. Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions.2016 · PubMed
  23. Natural Products for the Prevention and Treatment of Hangover and Alcohol Use Disorder.2016 · PubMed
  24. NATURAL PSYCHODYSLEPTIC COMPOUNDS: SOURCES AND PHARMACOLOGY2016 · OpenAlex
  25. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.2016 · PubMed
  26. Navigating HIV prevention policy and Islam in Malaysia: contention, compatibility or reconciliation? Findings from in-depth interviews among key stakeholders2016 · OpenAlex
  27. Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class2016 · OpenAlex
  28. Need for and Steps Toward a Clinical Guideline for the Telemental Healthcare of Children and Adolescents2016 · Crossref
  29. Negative Treatment by Family as a Predictor of Depressive Symptoms, Life Satisfaction, Suicidality, and Tobacco/Alcohol Use in Vietnamese Sexual Minority Women2016 · Crossref
  30. Neighborhood Socioeconomic Deprivation and Geographic Heterogeneity of Tobacco Environment in Missouri2016 · Crossref
  31. Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression2016 · OpenAlex
  32. Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities2016 · OpenAlex
  33. Network-Level Dysconnectivity in Drug-Naïve First-Episode Psychosis: Dissociating Transdiagnostic and Diagnosis-Specific Alterations2016 · OpenAlex
  34. Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders2016 · OpenAlex
  35. Neural Correlates of Craving in Methamphetamine Abuse2016 · OpenAlex
  36. Neural Correlates of Symptom Improvement Following Stimulant Treatment in Adults with Attention-Deficit/Hyperactivity Disorder2016 · Crossref
  37. Neural correlates of the LSD experience revealed by multimodal neuroimaging.2016 · PubMed
  38. Neurobiology of addiction: a neurocircuitry analysis.2016 · PubMed
  39. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse2016 · OpenAlex
  40. Neurobiology of opioid dependence in creating addiction vulnerability2016 · OpenAlex
  41. Neurofeedback training for alcohol dependence versus treatment as usual: study protocol for a randomized controlled trial2016 · OpenAlex
  42. Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression2016 · OpenAlex
  43. Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?2016 · OpenAlex
  44. Neuroleptic effect in aggressive mice after the transplantation of immune cells treated in vitro with chlorpromazine2016 · Crossref
  45. Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation2016 · OpenAlex
  46. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature2016 · OpenAlex
  47. Neuromodulation of the Feedforward Dentate Gyrus-CA3 Microcircuit2016 · OpenAlex
  48. Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation2016 · OpenAlex
  49. Neuropharmacological effects of the ethanolic extract of Sida acuta2016 · OpenAlex
  50. Neuropharmacology of N,N-dimethyltryptamine.2016 · PubMed
  51. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.2016 · PubMed
  52. Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder2016 · OpenAlex
  53. Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives2016 · OpenAlex
  54. Neuroprotective Effect of Phyllanthus acidus L. on Learning and Memory Impairment in Scopolamine-Induced Animal Model of Dementia and Oxidative Stress: Natural Wonder for Regulating the Development and Progression of Alzheimer’s Disease2016 · OpenAlex
  55. Neuroprotective effects of the ethanol stem bark extracts ofTerminalia ivorensisin ketamine-induced schizophrenia-like behaviors and oxidative damage in mice2016 · OpenAlex
  56. Neuropsychiatric pharmaceuticals and illicit drugs in wastewater treatment plants: a review2016 · OpenAlex
  57. Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches2016 · OpenAlex
  58. Neurotensin: A role in substance use disorder?2016 · Crossref
  59. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats2016 · OpenAlex
  60. Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark2016 · Crossref
  61. Neurotoxicity Induced by Mephedrone: An up-to-date Review2016 · OpenAlex
  62. Neutrophil myeloperoxidase and its substrates: formation of specific markers and reactive compounds during inflammation2016 · OpenAlex
  63. New approved nasal naloxone welcome, but unlicensed improvised naloxone spray kits remain a concern: proper scientific study must accompany innovation2016 · Crossref
  64. New iboga-type alkaloids from Ervatamia hainanensis2016 · Crossref
  65. New methodologies for faster study of new psychoactive substances: A proposal2016 · Crossref
  66. New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products2016 · Crossref
  67. New psychoactive substance α-PVP in a traffic accident case2016 · OpenAlex
  68. New York City Club Kids: A Contextual Understanding of Club Drug Use2016 · OpenAlex
  69. Newer substances and their effects: A case report2016 · OpenAlex
  70. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice.2016 · PubMed
  71. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans2016 · OpenAlex
  72. Nicotine Analysis in Several Non-Tobacco Plant Materials2016 · Crossref
  73. Nicotine and Carbonyl Emissions From Popular Electronic Cigarette Products: Correlation to Liquid Composition and Design Characteristics2016 · OpenAlex
  74. Nicotine receptor partial agonists for smoking cessation.2016 · PubMed
  75. Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review2016 · OpenAlex
  76. Nitenpyram degradation in finished drinking water2016 · Crossref
  77. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse2016 · OpenAlex
  78. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.2016 · PubMed
  79. No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit2016 · OpenAlex
  80. Non-alcoholic fatty liver and the gut microbiota2016 · OpenAlex
  81. Non-alcoholic fatty liver disease and diabetes2016 · OpenAlex
  82. Non-fatal overdose among opiate users in Wales: A national survey2016 · OpenAlex
  83. Non-medical use of olanzapine by people on methadone treatment2016 · OpenAlex
  84. Non-obstructive acute CoronarySyndrome and Khat chewing2016 · Crossref
  85. Non-small cell lung cancer: current treatment and future advances.2016 · PubMed
  86. Non-targeted screening for novel psychoactive substances among agitated emergency department patients2016 · OpenAlex
  87. Noninvasive Alcohol Monitoring Using a Wearable Tattoo-Based Iontophoretic-Biosensing System2016 · OpenAlex
  88. Noninvasive brain stimulation treatments for addiction and major depression2016 · OpenAlex
  89. Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence2016 · OpenAlex
  90. Nonmedical use of prescription drugs in the European Union2016 · OpenAlex
  91. Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?2016 · OpenAlex
  92. Nonoxidative ethanol metabolism in humans—from biomarkers to bioactive lipids2016 · OpenAlex
  93. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain2016 · OpenAlex
  94. Normative Perceptions of Cannabis Use Among European University Students: Associations of Perceived Peer Use and Peer Attitudes With Personal Use and Attitudes2016 · OpenAlex
  95. Not All Flavor Expertise Is Equal: The Language of Wine and Coffee Experts2016 · OpenAlex
  96. Notas sobre os usos contemporâneos do peiote2016 · OpenAlex
  97. Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers — United States, 2010–20152016 · OpenAlex
  98. Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant2016 · OpenAlex
  99. Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum2016 · OpenAlex
  100. Novel psychoactive substances2016 · Crossref